encyclopedia of medical concepts
ψ 

G(M2) Activator Protein

More information in Books or onNLM PubMed
Definition: An essential cofactor for the degradation of G(M2)GANGLIOSIDE by lysosomal BETA-N-ACETYLHEXOSAMINIDASES. Genetic mutations resulting in loss of G(M2) activator protein are one of the causes of TAY-SACHS DISEASE, AB VARIANT.      Other names Activator Protein, GM2; Hexosaminidase Activator; GM2 Activator Protein; GM(2) Activating Protein
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
GM2-N-acetyl-beta-D-galactosaminidase  EC 3.2.1.-   *Hexosaminidases *G(M2) Activator Protein. Clin Chim Acta 1980;108(3):361

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy